Mon, October 2, 2023
Sun, October 1, 2023
Fri, September 29, 2023
Thu, September 28, 2023
Wed, September 27, 2023
Tue, September 26, 2023
Mon, September 25, 2023
Fri, September 22, 2023

Ed Arce Reiterated (AKBA) at Strong Buy and Held Target at $3.75 on, Sep 27th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. uy-and-held-target-at-3-75-on-sep-27th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Ed Arce of HC Wainwright & Co., Reiterated "Akebia Therapeutics, Inc." (AKBA) at Strong Buy and Held Target at $3.75 on, Sep 27th, 2023.

Ed has made no other calls on AKBA in the last 4 months.



There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Ed's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ed


  • Christopher Raymond of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $4 on, Wednesday, May 31st, 2023

Publication Contributing Sources